199 related articles for article (PubMed ID: 29730546)
1. Increased plasmatic soluble HLA-G levels in endometrial cancer.
Ben Yahia H; Babay W; Bortolotti D; Boujelbene N; Laaribi AB; Zidi N; Kehila M; Chelbi H; Boudabous A; Mrad K; Mezlini A; Di Luca D; Ouzari HI; Rizzo R; Zidi I
Mol Immunol; 2018 Jul; 99():82-86. PubMed ID: 29730546
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection.
Laaribi AB; Bortolotti D; Hannachi N; Mehri A; Hazgui O; Ben Yahia H; Babay W; Belhadj M; Chaouech H; Yacoub S; Letaief A; Ouzari HI; Boudabous A; Di Luca D; Boukadida J; Rizzo R; Zidi I
J Viral Hepat; 2017 Nov; 24(11):1016-1022. PubMed ID: 28429836
[TBL] [Abstract][Full Text] [Related]
3. sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion.
Zidi I; Rizzo R; Bouaziz A; Laaribi AB; Zidi N; Di Luca D; Tlili H; Bortolotti D
Hum Immunol; 2016 Apr; 77(4):342-5. PubMed ID: 26812178
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of high circulating sHLA-G in ovarian carcinoma.
Babay W; Boujelbene N; Ben Yahia H; Bortolotti D; Zemni I; Ouzari HI; Chelbi H; Mezlini A; Rizzo R; Zidi I
HLA; 2021 Oct; 98(4):357-365. PubMed ID: 34272932
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.
Fainardi E; Bortolotti D; Castellazzi M; Casetta I; Bellini T; Rizzo R
Hum Immunol; 2020 Apr; 81(4):156-161. PubMed ID: 31735441
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term.
Klitkou L; Dahl M; Hviid TV; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Christiansen OB
Hum Immunol; 2015 Apr; 76(4):254-9. PubMed ID: 25636573
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
8. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
9. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
10. Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia.
He Y; Chen S; Huang H; Chen Q
J Perinat Med; 2016 Apr; 44(3):283-90. PubMed ID: 26352061
[TBL] [Abstract][Full Text] [Related]
11. The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients.
Veit TD; Chies JA; Switala M; Wagner B; Horn PA; Busatto M; Brenol CV; Tavares Brenol JC; Machado Xavier R; Rebmann V
PLoS One; 2015; 10(4):e0123838. PubMed ID: 25853899
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
13. Quantification and identification of soluble HLA-G isoforms.
Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
[TBL] [Abstract][Full Text] [Related]
14. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
[TBL] [Abstract][Full Text] [Related]
15. HLA-G5 in the blood of leukemia patients and healthy individuals.
Poláková K; Železníková T; Russ G
Leuk Res; 2013 Feb; 37(2):139-45. PubMed ID: 23146557
[TBL] [Abstract][Full Text] [Related]
16. Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma.
Di Cristofaro J; Karlmark KR; Kanaan SB; Azzouz DF; El Haddad M; Hubert L; Farge-Bancel D; Granel B; Harlé JR; Hachulla E; Pardoux E; Roudier J; Picard C; Lambert NC
Front Immunol; 2018; 9():1685. PubMed ID: 30158921
[TBL] [Abstract][Full Text] [Related]
17. Association of reduced maternal sHLA-G5 isoform levels and elevated TNF-α/IL-4 cytokine ratio with Recurrent Pregnancy Loss: A study on South Indian women.
Madduru D; Dirsipam K; Goli M; Ramana Devi V; Jahan P
Scand J Immunol; 2021 Oct; 94(4):e13095. PubMed ID: 34780078
[TBL] [Abstract][Full Text] [Related]
18. Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease.
Liu H; Chen Y; Xuan L; Wu X; Zhang Y; Fan Z; Huang F; Zhang X; Jiang Q; Sun J; Liu Q
Acta Haematol; 2013; 130(3):160-8. PubMed ID: 23711991
[TBL] [Abstract][Full Text] [Related]
19. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients?
Zidi I; Kharrat N; Sebai R; Zidi N; Ben Yahia H; Bouaziz A; Rifi H; Mezlini A; Rizzo R
Immunol Res; 2016 Apr; 64(2):636-9. PubMed ID: 26663018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
